Unlike the brain and spinal cord, peripheral nerve cells, whose long extensions reach the skin and internal organs, are ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to ...

EXPAREL is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block ...

Exparel is also used as a nerve block after surgery. In this case, the recommended dose is 133 mg given as a single dose. You’ll also likely take other medications for pain relief after surgery.

EXPAREL (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older, and postsurgical regional analgesia via ...

The FDA has approved a supplemental new drug application (sNDA) to expand the indication for bupivacaine liposome injectable suspension (Exparel; Pacira BioSciences, Inc.) for use in adult patients as ...

“The addition of these new blocks, coupled with the previously approved interscalene brachial plexus nerve block and the ability to utilize Exparel as a fascial plane block provides clinicians ...

Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, ...

In all three patients, targeted low-volume interscalene nerve blocks were administered and paired with systemic analgesia to promote effective closed glenohumeral reduction and limit the chance of ...